Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on L 1. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel patent CN118126005B details metal-free synthesis for high-purity intermediates. Enables cost reduction and scalable supply chain reliability for global pharmaceutical manufacturing partners.
Patent CN118619879A reveals a Rh-catalyzed route for trifluoromethyl enaminones. This method offers high purity, scalability, and cost-effective supply chain solutions for global pharmaceutical manufacturers.
Novel Pd-catalyzed serial cyclization for beta-halopyrroles. High purity, scalable process for pharma intermediates. Cost-effective supply chain solution.
Patent CN113429349A details a Cu/g-C3N4 catalyzed route for high-purity benzimidazoles, offering scalable production and cost-effective manufacturing solutions.
Novel Pd-catalyzed C-H activation method for 2-perfluoroalkyl indoles. Green oxidation, high regioselectivity, scalable for pharmaceutical intermediates.
Patent CN115286578B reveals metal-free synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel Rh-catalyzed method for benzimidazo[1,2-a]quinolines using ionic liquids. High yield, additive-free process for pharma intermediates.
Patent CN106631982A enables efficient carbazole synthesis. Offers supply chain reliability and cost reduction in pharmaceutical intermediates manufacturing for global partners.
Patent CN105936623B reveals a mild copper-catalyzed route to 3,4-cyclopentyl-1-tetralone, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel glucose-based route for trifluoromethyl triazoles. Mild conditions, high efficiency, scalable for API intermediates and fine chemicals.
Patent CN112480015B details a Pd-catalyzed one-pot method for 2-trifluoromethyl quinazolinones, offering cost reduction in API manufacturing and scalable supply chain solutions.
Patent CN115215810B reveals a catalyst-free heating method for triazole synthesis, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN115385916B reveals high-yield chiral synthesis. Offers cost reduction and supply reliability for pharmaceutical intermediate manufacturing globally.
Patent CN112480015B details a Pd-catalyzed one-pot method for 2-CF3 quinazolinones, offering cost reduction in pharmaceutical intermediate manufacturing via mild conditions.
Novel Mo/Cu co-catalyzed method offers mild conditions and high yields for critical API building blocks, ensuring supply chain stability.
Patent CN112480015B discloses a novel Pd-catalyzed one-pot method for 2-trifluoromethyl quinazolinones. High efficiency, scalable process for API intermediates.
Patent CN115286578B reveals metal-free room temperature synthesis. Offers cost reduction and supply chain reliability for high-purity pharmaceutical intermediates.
Patent CN115286578B reveals metal-free pyrazole synthesis. Enables cost reduction in pharma intermediate manufacturing with high purity and scalable room temperature processes.
Novel Pd-catalyzed route for complex ketene imines via enynone insertion. Mild conditions, high atom economy. Ideal for API intermediates and fine chemical manufacturing scale-up.
Patent CN106083649B details a novel two-step synthesis for cyclohexadiene derivatives, offering significant cost reduction and high yields for pharmaceutical intermediates manufacturing.